Oramed Pharmaceuticals
ORMP
#9183
Rank
โ‚ฌ0.16 B
Marketcap
3,91ย โ‚ฌ
Share price
-3.74%
Change (1 day)
86.04%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): โ‚ฌ53.41 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of โ‚ฌ55.59 Million, an increase over its 2024 earnings that were of -โ‚ฌ13.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ53.41 M-3.92%
2025 โ‚ฌ55.59 M-513.21%
2024 -โ‚ฌ13.46 Million-311.47%
2023 โ‚ฌ6.36 M-119.45%
2022 -โ‚ฌ32.71 Million39.17%
2021 -โ‚ฌ23.51 Million73.93%
2020 -โ‚ฌ13.52 Million18.53%
2019 -โ‚ฌ11.4 Million-16.62%
2018 -โ‚ฌ13.68 Million38.32%
2017 -โ‚ฌ9.89 Million12.51%
2016 -โ‚ฌ8.79 Million25.01%
2015 -โ‚ฌ7.03 Million18.18%
2014 -โ‚ฌ5.95 Million39.72%
2013 -โ‚ฌ4.26 Million46.4%
2012 -โ‚ฌ2.91 Million128.32%
2011 -โ‚ฌ1.28 Million-51.47%
2010 -โ‚ฌ2.63 Million35.21%
2009 -โ‚ฌ1.95 Million
2007 -โ‚ฌ3.06 Million607.04%
2006 -โ‚ฌ0.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚ฌ20.73 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚ฌ6.39 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.46 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ54.58 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ31.14 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel